DSE : ACMELAB

The ACME Laboratories Ltd. — Key statistics

Pharmaceutical Preparations · Bangladesh

Last price 77.9 BDT (At close: Oct 29, 2026) · Market cap 16.48B

Latest research: The ACME Laboratories valuation report: fair value BDT 64.9–137 (Oct 2026) · ACME's debt took 48% of FY2025 operating profit, limiting fair value to BDT 65–137 (base 105)

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap16.48B
Enterprise Value36.43B

Dates

MeasureValue
Earnings DateNov 3, 2026
Ex-Dividend DateNov 19, 2026

Shares

MeasureValue
Current Share Class211.60M
Shares Outstanding211.60M
Shares Change (YoY)n/a
Shares Change (QoQ)-0.05%
Owned by Insiders (%)34.86%
Owned by Institutions (%)7.51%
Float137.83M

Ratios

MeasureValue
PE Ratio6.18
Forward PEn/a
PS Ratio0.41
PB Ratio0.59
P/TBV Ratio0.59
P/FCF Ratio5.20
P/OCF Ratio2.88
PEG Ration/a

Evratios

MeasureValue
EV / Earnings13.67
EV / Sales0.91
EV / EBITDA4.07
EV / EBIT5.43
EV / FCF11.49

Financialposition

MeasureValue
Current Ratio1.20
Quick Ratio0.34
Debt / Equity0.85
Debt / EBITDA2.65
Debt / FCF7.49
Interest Coverage2.14

Financialefficiency

MeasureValue
Return on Equity (ROE)9.86%
Return on Assets (ROA)7.10%
Return on Invested Capital (ROIC)10.47%
Return on Capital Employed (ROCE)17.81%
Weighted Average Cost of Capital (WACC)7.82%
Revenue Per Employee4.44M
Profits Per Employee295,383
Employee Count9,025
Asset Turnover0.68
Inventory Turnover1.86

Taxes

MeasureValue
Income Tax906.27M
Effective Tax Rate25.37%

Stockprice

MeasureValue
Beta (5Y)0.11
52-Week Price Change+3.73%
50-Day Moving Average78.30
200-Day Moving Average78.10
Relative Strength Index (RSI)50.95
Average Volume (20 Days)110,249

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue40.05B
Gross Profit16.64B
Operating Income6.71B
Pretax Income3.57B
Net Income2.67B
EBITDA8.93B
EBIT6.71B
Earnings Per Share (EPS)12.60

Balancesheet

MeasureValue
Cash & Cash Equivalents3.81B
Total Debt23.76B
Net Cash-19.95B
Net Cash Per Share-94.28
Equity (Book Value)27.99B
Book Value Per Share132.27
Working Capital4.33B

Cashflow

MeasureValue
Operating Cash Flow5.73B
Capital Expenditures-2.56B
Depreciation & Amortization2.22B
Net Borrowing-1.41B
Free Cash Flow3.17B
FCF Per Share14.98

Margins

MeasureValue
Gross Margin41.55%
Operating Margin16.75%
Pretax Margin8.92%
Profit Margin6.66%
EBITDA Margin22.30%
EBIT Margin16.75%
FCF Margin7.92%

Dividends

MeasureValue
Dividend Per Share3.50
Dividend Yield4.49%
Dividend Growth (YoY)14.29%
Years of Dividend Growthn/a
Payout Ratio27.80%
FCF Payout Ratio26.70%
Buyback Yieldn/a
Shareholder Yield4.49%
Earnings Yield16.17%
FCF Yield19.23%

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Score1.81
Piotroski F-Score6

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside